Głuszczyk, A. et al. 2024. Challenges and risks of using GLP-1 antagonists in treating type 2 diabetes and obesity. Quality in Sport. 17, (Aug. 2024), 53683. DOI:https://doi.org/10.12775/QS.2024.17.53683.